172 related articles for article (PubMed ID: 16128604)
1. Medical nanotechnology: shortening clinical trials and regulatory pathways?
Ferrari M; Downing G
BioDrugs; 2005; 19(4):203-10. PubMed ID: 16128604
[TBL] [Abstract][Full Text] [Related]
2. Towards more effective advanced drug delivery systems.
Crommelin DJ; Florence AT
Int J Pharm; 2013 Sep; 454(1):496-511. PubMed ID: 23415662
[TBL] [Abstract][Full Text] [Related]
3. Nanoscale drug delivery for targeted chemotherapy.
Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
[TBL] [Abstract][Full Text] [Related]
4. Nanotechnology-based drug delivery systems in orthopedics.
Güven E
Jt Dis Relat Surg; 2021; 32(1):267-273. PubMed ID: 33463450
[TBL] [Abstract][Full Text] [Related]
5. Recent expansion of pharmaceutical nanotechnologies and targeting strategies in the field of phytopharmaceuticals for the delivery of herbal extracts and bioactives.
Alexander A; Ajazuddin ; Patel RJ; Saraf S; Saraf S
J Control Release; 2016 Nov; 241():110-124. PubMed ID: 27663228
[TBL] [Abstract][Full Text] [Related]
6. Accelerating safe drug development: an ideal approach to approval.
Grever MR
Hematology Am Soc Hematol Educ Program; 2013; 2013():24-9. PubMed ID: 24319158
[TBL] [Abstract][Full Text] [Related]
7. Micro- and nanotechnologies for intelligent and responsive biomaterial-based medical systems.
Caldorera-Moore M; Peppas NA
Adv Drug Deliv Rev; 2009 Dec; 61(15):1391-401. PubMed ID: 19758574
[TBL] [Abstract][Full Text] [Related]
8. Nanostructure-mediated drug delivery.
Hughes GA
Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054
[TBL] [Abstract][Full Text] [Related]
9. Regulatory inspection of clinical trials in Nigeria.
Keri HJ
Nig Q J Hosp Med; 2008; 18(2):120-2. PubMed ID: 19068566
[No Abstract] [Full Text] [Related]
10. Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study.
Eifler AC; Thaxton CS
Methods Mol Biol; 2011; 726():325-38. PubMed ID: 21424459
[TBL] [Abstract][Full Text] [Related]
11. [Molecular imaging-based early-phase and exploratory clinical research].
Watanabe Y
Yakugaku Zasshi; 2013; 133(2):187-95. PubMed ID: 23370512
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of graphene in biomedical applications.
Foo ME; Gopinath SCB
Biomed Pharmacother; 2017 Oct; 94():354-361. PubMed ID: 28772213
[TBL] [Abstract][Full Text] [Related]
13. Advances and Implications in Nanotechnology for Lung Cancer Management.
Sarkar S; Osama K; Jamal QMS; Kamal MA; Sayeed U; Khan MKA; Siddiqui MH; Akhtar S
Curr Drug Metab; 2017; 18(1):30-38. PubMed ID: 27842486
[TBL] [Abstract][Full Text] [Related]
14. Role of nanotechnology in targeted drug delivery and imaging: a concise review.
Koo OM; Rubinstein I; Onyuksel H
Nanomedicine; 2005 Sep; 1(3):193-212. PubMed ID: 17292079
[TBL] [Abstract][Full Text] [Related]
15. Has nanotechnology led to improved therapeutic outcomes?
Bosselmann S; Williams RO
Drug Dev Ind Pharm; 2012 Feb; 38(2):158-70. PubMed ID: 22191583
[TBL] [Abstract][Full Text] [Related]
16. Identifying quality leads - an important factor in reducing attrition of clinical candidates.
Chackalamannil S; Desai MC
Curr Opin Drug Discov Devel; 2007 Jul; 10(4):381-2. PubMed ID: 17659478
[No Abstract] [Full Text] [Related]
17. The role of nanobiotechnology in drug discovery.
Jain KK
Drug Discov Today; 2005 Nov; 10(21):1435-42. PubMed ID: 16243263
[TBL] [Abstract][Full Text] [Related]
18. Exploring emerging nanobiotechnology drugs and medical devices.
Paradise J; Diliberto GM; Tisdale AW; Kokkoli E
Food Drug Law J; 2008; 63(2):407-20. PubMed ID: 18561467
[No Abstract] [Full Text] [Related]
19. Selected contributions from the 10th European Workshop on Particulate Systems, Copenhagen 19th-20th January 2017.
Foged C
Int J Pharm; 2018 Sep; 548(2):729. PubMed ID: 29883794
[No Abstract] [Full Text] [Related]
20. Advanced drug delivery in motion.
Mastrobattista E
Int J Pharm; 2013 Sep; 454(1):517-20. PubMed ID: 23665006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
